[Piperacillin in the treatment of suppurative inflammatory complications in cancer patients]. / Piperatsillin pri lechenii gnoino-vospalitel'nykh oslozhnenii u onkologicheskikh bol'nykh.
Antibiot Khimioter
; 38(10-11): 35-9, 1993.
Article
em Ru
| MEDLINE
| ID: mdl-8085891
ABSTRACT
Piperacillin (Pipril, Lederle, USA) is semisynthetic penicillin highly active against aerobic and anaerobic organisms. Its high activity was demonstrated with respect to 289 strains of aerobes, 82.7 per cent of the Pseudomonas aeruginosa strains being susceptible to Pipril. Diverse purulent inflammatory complications were treated with Pipril in doses of 8 to 24 g a day in 27 patients with malignant tumors. The clinical effect in 84.6 per cent of the cases was recorded. Complete elimination of the pathogens was observed in 73.5 per cent of the patients. Therefore, Pipril should be considered as one of the most active antibiotics for the treatment of purulent inflammatory complications in oncological patients.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piperacilina
/
Infecções Bacterianas
/
Infecção Hospitalar
/
Neoplasias
Tipo de estudo:
Etiology_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Revista:
Antibiot Khimioter
Assunto da revista:
TERAPIA POR MEDICAMENTOS
Ano de publicação:
1993
Tipo de documento:
Article
País de publicação:
FEDERAÇÃO RUSSA
/
RU
/
RUSIA
/
RUSSIA